Subcutaneous cysticercosis;CYSTICERCOSE SOUS-CUTANEE

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 8, 1996, Pages 474-477

  Del Giudice, P ^a   Bernard, E ^a   Perrin, C ^b   Marty, P ^c   Le Fichoux, Y ^c   Ortonne, J P ^b   Michiels, J F ^b   Dellamonica, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b PASTEUR HOSPITAL   (France)

^c University of Côte d'Azur   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTIPARASITIC AGENT; ANTIPLATYHELMINTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CYSTICERCOSIS; HUMAN; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; SEIZURE; BRAIN DISEASE; EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITIC SKIN DISEASE; REVIEW; TREATMENT FAILURE;

ADULT; ANTIPARASITIC AGENTS; ANTIPLATYHELMINTIC AGENTS; BRAIN DISEASES; CYSTICERCOSIS; EPILEPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PRAZIQUANTEL; SKIN DISEASES, PARASITIC; TREATMENT FAILURE;

EID: 0029742907     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jones TC. Cestodes (tapeworms). In: Mandell GL, Douglas RG, Benett JE, eds. Principles and practice of infectious diseases, 2nd ed. New York: John Wiley & Sons, 1985:1581.
2. Tschen EH, Tschen EA, Smith EB. Cutaneous cysticercosis treated with metrifonate. Arch Dermatol 1981;117:507-9.
3. Raimer S, Wolf JE. Subcutaneous cysticercosis. Arch Dermatol 1978;114:107-8.
4. Marty P, Herzog U, Marty-Jaussan I, Le Fichoux Y, Doucet J. Deux cas de cysticercose observés au Cameroun. Med Trop 1985; 45:83-6.
5. Beaver PC, Jung RC, Cupp EW. Clinical parasitology, 9th ed. Philadelphia: Lea & Febiger, 1984:513-9.
6. Hunter GW, Freyes WW, Swartzwelder JC. A manual of tropical medecine. Philadelphia: WB Saunders, 1966:572.
7. Brumpt L. Cestodes. In: Woodruff AW, Wright SG, eds. Medecine in the tropics, 2nd ed. New York: Churchill Livingstone, 1984:134-9.
8. Pawlowski ZK. Cestode infections. Cestodes: taeniasis, diphyllobothriasis, hymenolepiasis and others. In: Warren KS, Mahmoud AA, eds. Tropical and geographical medecine. New York: McGraw-Hill, 1984:474-9.
9. Farah FS. Protozoan and helminthic infections. In: Fitzpatrick TB, Eisen AZ, Wolff K et al., eds. Dermatology in general medecine, 3rd ed. New York: McGraw-Hill, 1987:2488-9.
10. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Med Res Spec Rep (Lond.) 1961:1-58.
11. Wortman PD. Subcutaneous cysticercosis. J Am Acad Dermatol 1991;25:409-14.
12. O'Gray T, Robbins BA, Barrett TL, Higginbottom PA. Subcutaneous cysticercosis simulating metastatic breast carcinoma. Int J Dermatol 1993;32:62-4.
13. Puppin D, Cavegn BM, Delmaestro D. Subcutaneous cysticercosis of the tongue mimicking a tumor. Int J Dermatol 1993; 32:818-9.
14. Quimosing EM, Conde J, Cross JH. Subcutaneous and cerebral cysticercosis treated with praziquantel. Southeast Asian J Trop Med Public Health 1984;15:201-5.
15. Botero D. Cysticercosis. In: Goldsmith R, Heyneman D, eds. Tropical medecine and parasitology. Norwalk, CT: Appleton & Lange, 1989:497.
16. Goldsmith RS. Recent advances in the treatment of helminthic infections: ivermectin, albendazole and praziquantel. In: Leech JH, Sarde MA, Rect RK, eds. Parasitic infections. New York/Edinbourg/London/Melbourne: Churchill Livingstone, 1988:327.
17. Baranski MC. Treatment of dermal cysticercosis with praziquantel, a new cestocidal agent. Rev Inst Med Trop Sao Paulo 1984;26:259-66.
18. Takayanagui OM, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-4.
19. Chotmongkol V. Treatment of neurocysticercosis with a two week course of albendazole. Southeast Asian J Trop Med Public Health 1985;24:396-8.
20. Del Brutto OH, Sotelo J, Roman GC. Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis 1993;17:730-5.
21. Botero D, Uribe CS, Sanchez JL, Alzate T, Velasquez G, Ocampo NE et al. Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 1993; 87:576-7.
22. Falanga V, Kapoor W. Cerebral cysticercosis: diagnostic value of subcutaneous nodules. J Am Acad Dermatol 1985;12:304-7.
23. McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri. Review of 127 cases. Arch Neurol 1982;39:534-9.
24. Jena A, Sanchetee PC, Gupta RK et al. Cysticercosis of the brain shown by magnetic resonance imaging. Clin Radiol 1988;39: 542-6
25. Nzisabira L, Nsengiyumva, Bouteille B, Ndayirgije A, Niyongabo Th, Bigirimana V et al. La cysticercose dans la province de Kayanga (Burundi). Bull Soc Path Ex 1992;85:374-7.
26. King CH, Mahmoud AAF. Drugs five years later: praziquantel. Ann Intern Med 1989;110:290-6.
27. Joubert J, Joubert MJ, Lombard CM. Neurocysticercosis - a comprehensive approach to medical treatment. S Afr Med J 1985;68:11-4.
28. Sotelo J, Escobeio F, Penago P. Albendazole versus praziquantel for therapy for neurocysticercosis: a controlled trial. Arch Neurol 1988;45:532-4.
29. Jordaan HF, Schneider JW, Cilliers J. Cerebral and subcutaneous cysticercosis treated with albendazole. Int J Dermatol 1995;34:574-9.
30. Del Brutto OH, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis 1988;10:1075-87.